Search

everythinglearnresearchcommunity

for

Search:↓

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

Prostate size varies by ethnic group, age, residence, and blood glucose, but not by body measurements or fat.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Premature hair loss doesn't increase the risk of metabolic syndrome.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Bald men may have a higher risk of heart disease, but baldness doesn't necessarily mean more severe heart disease.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

Higher variability in systolic blood pressure increases long-term mortality risk in coronary artery disease patients.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Finasteride lowers cholesterol but doesn't reduce heart-related events.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

A new method accurately measures nine specific hormones in human blood.

Venlafaxine can cause urinary incontinence in rare cases.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.